BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31231982)

  • 1. Effect of dose constraint on the thyroid gland during locoregional intensity-modulated radiotherapy in breast cancer patients.
    Haciislamoglu E; Canyilmaz E; Gedik S; Aynaci O; Serdar L; Yoney A
    J Appl Clin Med Phys; 2019 Jul; 20(7):135-141. PubMed ID: 31231982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study.
    Tunio MA; Al Asiri M; Bayoumi Y; Stanciu LG; Al Johani N; Al Saeed EF
    J Cancer Res Ther; 2015; 11(4):684-9. PubMed ID: 26881502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery.
    Zhang F; Wang Y; Xu W; Jiang H; Liu Q; Gao J; Yao B; Hou J; He H
    Technol Cancer Res Treat; 2015 Oct; 14(5):515-23. PubMed ID: 25311257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dosimetry study precisely outlining the heart substructure of left breast cancer patients using intensity-modulated radiation therapy.
    Fan LL; Luo YK; Xu JH; He L; Wang J; Du XB
    J Appl Clin Med Phys; 2014 Sep; 15(5):4624. PubMed ID: 25207559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays.
    Hayashi A; Shibamoto Y; Hattori Y; Tamura T; Iwabuchi M; Otsuka S; Sugie C; Yanagi T
    J Radiat Res; 2015 Mar; 56(2):338-45. PubMed ID: 25609741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy.
    Höfel S; Gandalini M; Fix MK; Drescher M; Zwicker F
    Radiat Oncol; 2021 Oct; 16(1):209. PubMed ID: 34717680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment planning comparison of volumetric modulated arc therapy with the trilogy and the Halcyon for bilateral breast cancer.
    Sun T; Lin X; Zhang G; Qiu Q; Li C; Yin Y
    Radiat Oncol; 2021 Feb; 16(1):35. PubMed ID: 33602267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: dosimetric evaluation.
    Caudrelier JM; Morgan SC; Montgomery L; Lacelle M; Nyiri B; Macpherson M
    Radiother Oncol; 2009 Jan; 90(1):99-105. PubMed ID: 18977546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison between helical tomotherapy and intensity-modulated radiation therapy plans for non-small cell lung cancer.
    Meng LL; Feng LC; Wang YL; Dai XK; Xie CB
    Chin Med J (Engl); 2011 Jun; 124(11):1667-71. PubMed ID: 21740774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric comparison between jaw tracking and static jaw techniques in intensity-modulated radiotherapy.
    Feng Z; Wu H; Zhang Y; Zhang Y; Cheng J; Su X
    Radiat Oncol; 2015 Jan; 10():28. PubMed ID: 25623899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison of intensity-modulated radiotherapy plans, with or without anterior myocardial territory and left ventricle as organs at risk, in early-stage left-sided breast cancer patients.
    Tan W; Wang X; Qiu D; Liu D; Jia S; Zeng F; Chen Z; Li B; Xu J; Wei L; Hu D
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1544-51. PubMed ID: 21470785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
    Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
    Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Static beam tomotherapy as an optimisation method in whole-breast radiation therapy (WBRT).
    Squires M; Hu Y; Byrne M; Archibald-Heeren B; Cheers S; Bosco B; Teh A; Fong A
    J Med Radiat Sci; 2017 Dec; 64(4):281-289. PubMed ID: 28580762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior myocardial territory may replace the heart as organ at risk in intensity-modulated radiotherapy for left-sided breast cancer.
    Tan W; Liu D; Xue C; Xu J; Li B; Chen Z; Hu D; Wang X
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1689-97. PubMed ID: 21621342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetry of intensity-modulated radiation therapy and volumetric-modulated arc therapy techniques after modified radical mastectomy for breast cancer and hypofractionated intensity-modulated radiotherapy.
    Lin H; Sheng X; Liu H; Zhang P; Liu Y; Zang C
    J Cancer Res Ther; 2023 Dec; 19(6):1568-1574. PubMed ID: 38156923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dosimetric analysis of volumetric modulated arc therapy and intensity modulated radiotherapy for patients undergone breast-conserving operation].
    Sun HT; Yang RJ; Jiang P; Jiang WJ; Li JN; Meng N; Wang JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):188-192. PubMed ID: 29483745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.
    Lomax AJ; Cella L; Weber D; Kurtz JM; Miralbell R
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):785-92. PubMed ID: 12573766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we consider thyroid gland as an organ at risk in carcinoma breast patients receiving adjuvant radiation by conformal technique? A single institute dosimetric study.
    Madisetty A; Suryadevara A; Chinta SK; Vuppu S; R Marella VR
    Indian J Cancer; 2020; 57(4):393-397. PubMed ID: 33078745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.